Prelude Therapeutics and AbCellera Enter Partnership to Develop First-in-Class Precision Antibody Drug Conjugates in Oncology
01 nov. 2023 16h05 HE
|
Prelude Therapeutics, Inc.; AbCellera
Prelude Therapeutics and AbCellera Enter Partnership to Develop First-in-Class Precision Antibody Drug Conjugates in Oncology
AbCellera Receives Grant to Help Fight Tuberculosis
19 janv. 2017 09h00 HE
|
AbCellera
AbCellera received a grant from the Bill & Melinda Gates Foundation to discover antibodies against Mycobacterium tuberculosis.VANCOUVER, British Columbia, Jan. 19, 2017 (GLOBE NEWSWIRE) --...
AbCellera and MassBiologics Partner to Discover Fully Human Antibodies Against Drug-Resistant Bacteria
20 juil. 2016 09h00 HE
|
AbCellera
VANCOUVER, British Columbia, July 20, 2016 (GLOBE NEWSWIRE) -- AbCellera Biologics Inc., a biotechnology company specializing in the rapid discovery of monoclonal antibodies from natural immune...